Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.


TSXV:MIR - Post by User

Bullboard Posts
Post by pairof4on Jul 23, 2020 3:20am
303 Views
Post# 31306001

False positive

False positiveThe FDA must be walking on eggs.

Ninety out of 144 Covid-19 tests were wrong

  •  
  •  
  •  
  •  

“Ninety out of 144. That is a failure rate of of 68.75%. We cannot trust ANY of the data.”
– Benjamin Napier
_______________

Ninety people who received positive COVID-19 results did not have the virus, according to the Connecticut state Department of Public Health.

The department said the state public health laboratory uncovered a flaw in one of the testing systems it uses to test for SARS-CoV-2, the virus that causes COVID-19, and 90 of 144 people tested between June 15 and July 17 received a false positive COVID test report. Many are nursing home residents.

According to the state Department of Health, the errant testing results were “from a widely-used laboratory testing platform that the state laboratory started using on June 15.”

https://www.msn.com/en-us/health/medical/state-lab-finds-90-positive-covid-19-test-results-were-false/ar-BB16Yche?ocid=mmx&fbclid=IwAR0YgLMiQBb2wuARnrKDVbt-qn99nFHt7KsYkQDy8owBCdpyWVGstMm7xVE

Thanks to Benjamin Napier for this link


Bullboard Posts